Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer (Oncogene, (2016), 35, 12, (1517-1528), 10.1038/onc.2015.214);Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer

Oncogene

Volumn 35, Issue 12, 2016, Pages 1517-1528

  Chang, Y W ^a   Tseng, C F ^a,b   Wang, M Y ^c   Chang, W C ^d   Lee, C C ^e   Chen, L T ^a   Hung, M C ^f   Su, J L ^a,d,g,h  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ACADEMIA SINICA   (Taiwan)

^f UNIVERSITY OF TEXAS   (United States)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GP78 PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 5; HISTONE DEACETYLASE 6; LYSINE; POLYUBIQUITIN; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; HDAC6 PROTEIN, HUMAN; HISTONE DEACETYLASE; MOLECULAR CHAPERONE GRP78;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DEACETYLATION; EXPERIMENTAL METASTASIS; FEMALE; HELA CELL LINE; HISTONE ACETYLATION; HISTONE UBIQUITINATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MCF 7 CELL LINE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN STABILITY; TUMOR INVASION; ACETYLATION; AMINO ACID SEQUENCE; ANIMAL; BREAST TUMOR; CHEMISTRY; GENE SILENCING; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; SCID MOUSE; SEQUENCE HOMOLOGY; TUMOR CELL LINE; UBIQUITINATION;

ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE KNOCKDOWN TECHNIQUES; HEAT-SHOCK PROTEINS; HISTONE DEACETYLASES; HUMANS; MICE, SCID; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEASOME ENDOPEPTIDASE COMPLEX; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITINATION;

EID: 84933557467     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-019-0981-5     Document Type: Erratum

References (70)

1. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res 2007; 67: 3496-3499
2. Luo S, Mao C, Lee B, Lee AS. GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development. Mol Cell Biol 2006; 26: 5688-5697
3. Wang Q, He Z, Zhang J, Wang Y, Wang T, Tong S, et al. Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance. Cancer Detect Prev 2005; 29: 544-551
4. Fernandez PM, Tabbara SO, Jacobs LK, Manning FC, Tsangaris TN, Schwartz AM, et al. Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat 2000; 59: 15-26
5. Gazit G, Lu J, Lee AS. De-regulation of GRP stress protein expression in human breast cancer cell lines. Breast Cancer Res Treat 1999; 54: 135-146
6. Pootrakul L, Datar RH, Shi SR, Cai J, Hawes D, Groshen SG, et al. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer. Clin Cancer Res 2006; 12: 5987-5993
7. Xing X, Lai M, Wang Y, Xu E, Huang Q. Overexpression of glucose-regulated protein 78 in colon cancer. Clin Chim Acta 2006; 364: 308-315
8. Zhang J, Jiang Y, Jia Z, Li Q, Gong W, Wang L, et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis 2006; 23: 401-410
9. Chang YJ, Chiu CC, Wu CH, An J, Wu CC, Liu TZ, et al. Glucose-regulated protein 78 (GRP78) silencing enhances cell migration but does not influence cell proliferation in hepatocellular carcinoma. Ann Surg Oncol 2010; 17: 1703-1709
10. Haga A, Komazaki S, Funasaka T, Hashimoto K, Yokoyama Y, Watanabe H, et al. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78. Leuk Lymphoma 2006; 47: 2234-2243
11. Dong D, Ni M, Li J, Xiong S, Ye W, Virrey JJ, et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 2008; 68: 498-505
12. Dong D, Stapleton C, Luo B, Xiong S, Ye W, Zhang Y, et al. A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis. Cancer Res 2011; 71: 2848-2857
13. Hicke L. A new ticket for entry into budding vesicles-ubiquitin. Cell 2001; 106: 527-530
14. Sommer T, Wolf DH. The ubiquitin-proteasome-system. Biochim Biophys Acta 2014; 1843: 1
15. Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem 2009; 78: 399-434
16. Sun Y. E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 2006; 8: 645-654
17. Fang S, Ferrone M, Yang C, Jensen JP, Tiwari S, Weissman AM. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc Natl Acad Sci USA 2001; 98: 14422-14427
18. Ying Z, Wang H, Fan H, Zhu X, Zhou J, Fei E, et al. Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Hum Mol Genet 2009; 18: 4268-4281
19. Joshi B, Li L, Nabi IR. A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase. J Biol Chem 2010; 285: 8830-8839
20. Tsai YC, Mendoza A, Mariano JM, Zhou M, Kostova Z, Chen B, et al. The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med 2007; 13: 1504-1509
21. Hirono Y, Fushida S, Yonemura Y, Yamamoto H, Watanabe H, Raz A. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. Br J Cancer 1996; 74: 2003-2007
22. Jo Y, Debose-Boyd RA. Control of cholesterol synthesis through regulated ERassociated degradation of HMG CoA reductase. Crit Rev Biochem Mol Biol 2010; 45: 185-198
23. Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006; 6: 38-51
24. Lee AS, Hendershot LM. ER stress and cancer. Cancer Biol Ther 2006; 5: 721-722
25. Chiu CC, Lin CY, Lee LY, Chen YJ, Kuo TF, Chang JT, et al. Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention. Mol Cancer Ther 2008; 7: 2788-2797
26. Chang YW, Chen HA, Tseng CF, Hong CC, Ma JT, Hung MC, et al. De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells. Oncotarget 2014; 5: 10558-10570
27. Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 2005; 18: 601-607
28. Yang Y, Rao R, Shen J, Tang Y, Fiskus W, Nechtman J, et al. Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res 2008; 68: 4833-4842
29. Rao R, Fiskus W, Yang Y, Lee P, Joshi R, Fernandez P, et al. HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells. Blood 2008; 112: 1886-1893
30. Rao R, Nalluri S, Kolhe R, Yang Y, Fiskus W, Chen J, et al. Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells. Mol Cancer Ther 2010; 9: 942-952
31. Chen B, Mariano J, Tsai YC, Chan AH, Cohen M, Weissman AM. The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. Proc Natl Acad Sci USA 2006; 103: 341-346
32. Carlsson L, Lazarides E. ADP-ribosylation of the Mr 83, 000 stress-inducible and glucose-regulated protein in avian and mammalian cells: modulation by heat shock and glucose starvation. Proc Natl Acad Sci USA 1983; 80: 4664-4668
33. Hendershot LM, Ting J, Lee AS. Identity of the immunoglobulin heavy-chainbinding protein with the 78, 000-dalton glucose-regulated protein and the role of posttranslational modifications in its binding function. Mol Cell Biol 1988; 8: 4250-4256
34. Freiden PJ, Gaut JR, Hendershot LM. Interconversion of three differentially modified and assembled forms of Bi P. EMBO J 1992; 11: 63-70
35. Satoh M, Nakai A, Sokawa Y, Hirayoshi K, Nagata K. Modulation of the phosphorylation of glucose-regulated protein, GRP78, by transformation and inhibition of glycosylation. Exp Cell Res 1993; 205: 76-83
36. Kundrat L, Regan L. Identification of residues on Hsp70 and Hsp90 ubiquitinated by the cochaperone CHIP. J Mol Biol 2010; 395: 587-594
37. Bertrand J, Tennoune N, Marion-Letellier R, Goichon A, Chan P, Mbodji K, et al. Evaluation of ubiquitinated proteins by proteomics reveals the role of the ubiquitin proteasome system in the regulation of Grp75 and Grp78 chaperone proteins during intestinal inflammation. Proteomics 2013; 13: 3284-3292
38. Lopitz-Otsoa F, Rodriguez-Suarez E, Aillet F, Casado-Vela J, Lang V, Matthiesen R, et al. Integrative analysis of the ubiquitin proteome isolated using Tandem Ubiquitin Binding Entities (TUBEs). J Proteomics 2012; 75: 2998-3014
39. Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitinproteasome pathway in normal and disease states. J Am Soc Nephrol 2006; 17: 1807-1819
40. Wang Y, Kim SM, Trnka MJ, Liu Y, Burlingame AL, Correia MA. Human liver cytochrome P450 3A4 ubiquitination: molecular recognition by UBC7-gp78 autocrine motility factor receptor and UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 ubiquitin ligase complexes. J Biol Chem 2015; 290: 3308-3332
41. Wang X, Ma X, Wang H, Li B, Clark G, Guo Y, et al. Proteomic study of microsomal proteins reveals a key role for Arabidopsis annexin 1 in mediating heat stressinduced increase in intracellular calcium levels. Mol Cell Proteomics 2015; 14: 686-694
42. Song BL, Sever N, DeBose-Boyd RA. Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol Cell 2005; 19: 829-840
43. Liang JS, Kim T, Fang S, Yamaguchi J, Weissman AM, Fisher EA, et al. Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. J Biol Chem 2003; 278: 23984-23988
44. Zhang T, Kho DH, Wang Y, Harazono Y, Nakajima K, Xie Y, et al. Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer. PLoS One 2015; 10: e0118448
45. Floriano-Sanchez E, Rodriguez NC, Bandala C, Coballase-Urrutia E, Lopez-Cruz J. CYP3A4 expression in breast cancer and its association with risk factors in Mexican women. Asian Pac J Cancer Prev 2014; 15: 3805-3809
46. Zia H, Murray GI, Vyhlidal CA, Leeder JS, Anwar AE, Bui MM, et al. CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation. Int J Exp Pathol 2015; 96: 81-86
47. Fujimura T, Takahashi S, Urano T, Tanaka T, Zhang W, Azuma K, et al. Clinical significance of steroid and xenobiotic receptor and its targeted gene CYP3A4 in human prostate cancer. Cancer Sci 2012; 103: 176-180
48. Sakurai K, Enomoto K, Matsuo S, Amano S, Shiono M. CYP3A4 expression to predict treatment response to docetaxel for metastasis and recurrence of primary breast cancer. Surg Today 2011; 41: 674-679
49. Schointuch MN, Gilliam TP, Stine JE, Han X, Zhou C, Gehrig PA, et al. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer. Gynecol Oncol 2014; 134: 346-355
50. His M, Zelek L, Deschasaux M, Pouchieu C, Kesse-Guyot E, Hercberg S, et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol 2014; 29: 119-132
51. Fairbank M, St-Pierre P, Nabi IR. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase. Mol Biosyst 2009; 5: 793-801
52. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303: 844-848
53. Bassermann F, Eichner R, Pagano M. The ubiquitin proteasome system -implications for cell cycle control and the targeted treatment of cancer. Biochim Biophys Acta 2014; 1843: 150-162
54. Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest 2002; 110: 633-641
55. Chan CH, Li CF, Yang WL, Gao Y, Lee SW, Feng Z, et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 2012; 149: 1098-1111
56. Fang S, Lorick KL, Jensen JP, Weissman AM. RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Semin Cancer Biol 2003; 13: 5-14
57. Li M, Yu X. Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell 2013; 23: 693-704
58. Hesling C, D'Incan M, D'Incan C, Souteyrand P, Monboisse JC, Pasco S, et al. Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression. J Invest Dermatol 2004; 122: 369-380
59. Joukov V, Groen AC, Prokhorova T, Gerson R, White E, Rodriguez A, et al. The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly. Cell 2006; 127: 539-552
60. Wong CS, Moller A. Siah: a promising anticancer target. Cancer Res 2013; 73: 2400-2406
61. Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov 2011; 10: 29-46
62. Wang Y, Guan S, Acharya P, Liu Y, Thirumaran RK, Brandman R, et al. Multisite phosphorylation of human liver cytochrome P450 3A4 enhances Its gp78-and CHIP-mediated ubiquitination: a pivotal role of its Ser-478 residue in the gp78-catalyzed reaction. Mol Cell Proteomics 2012; 11: 010132
63. McFadyen MC, Melvin WT, Murray GI. Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol Cancer Ther 2004; 3: 363-371
64. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R, et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997; 17: 353-360
65. Su JL, Chen PB, Chen YH, Chen SC, Chang YW, Jan YH, et al. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res 2010; 70: 5096-5108
66. Festing MF, Altman DG. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 2002; 43: 244-258
67. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006; 9: 121-132
68. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2, 000 breast tumours reveals novel subgroups. Nature 2012; 486: 346-352
69. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004; 5: 607-616
70. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 2011; 305: 1873-1881